Notice2026-06577
Advisory Committee on Immunization Practices (ACIP); Notice of Charter Renewal
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 6, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
Notice is hereby given, in accordance with the Federal Advisory Committee Act of October 6, 1972, that the Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through April 1, 2028.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 65 (Monday, April 6, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 65 (Monday, April 6, 2026)]
[Notices]
[Pages 17279-17280]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-06577]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP); Notice of
Charter Renewal
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of charter renewal.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given, in accordance with the Federal
Advisory Committee Act of October 6, 1972, that the Advisory Committee
on Immunization Practices (ACIP), Centers for Disease Control and
Prevention, Department of Health and Human Services, has been renewed
for a 2-year period through April 1, 2028.
FOR FURTHER INFORMATION CONTACT: ACIP Secretariat, Advisory Committee
on Immunization Practices, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H21-12, Atlanta, Georgia 30329-4027.
Email: <a href="/cdn-cgi/l/email-protection#1455575d44547770773a737b62"><span class="__cf_email__" data-cfemail="df9e9c968f9fbcbbbcf1b8b0a9">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In accordance with the Federal Advisory
Committee Act, as amended, CDC is providing notice of the renewal of
the charter of the Advisory Committee on Immunization Practices,
Centers for Disease Control and Prevention, Department of Health and
Human Services. This charter has been renewed for a two-year period
through April 1, 2028.
Public Interest Determination
Pursuant to 41 CFR 102-3.60(a), to establish, renew, reestablish,
or merge a discretionary (agency discretion) advisory committee, an
agency must first consult with the General Services Administration's
Committee Management Secretariat (the Secretariat) and, as part of the
consultation, provide a written public interest determination approved
by the head of the agency to the Secretariat with a copy to the Office
of Management and Budget. In addition, pursuant to 41 CFR 102-3.35, an
agency shall follow the same consultation process and document in
writing the same determination of need before creating a subcommittee
under a discretionary committee that is not made up entirely of members
of a parent advisory committee.
Information on the following factors for the committee is provided
to the Secretariat to demonstrate that renewing the committee is in the
public interest:
1. Annual budget: The ACIP's estimated annual costs for operating
the Committee, including (i) Federal personnel and other Federal
internal costs; (ii) proposed payments for up to 19 members; and (iii)
reimbursable costs are as follows: a. Federal personnel on a full-time
equivalent (FTE) basis, $940,313; b. Other Federal internal costs,
$140,027; c. Proposed payments to members, $42,750; d. Proposed number
of members: The anticipated number of members for ACIP is up to 19; e.
Reimbursable costs, $83,106;
2. If applicable, the total dollar value of grants expected to be
recommended during the fiscal year, $0.
3. Criteria for selecting members to ensure the committee has the
necessary expertise and fairly balanced membership: Departmental policy
provides that Committee membership be fairly balanced in terms of
points of view represented, and the Committee's function. Consideration
is also given to representation from diverse geographic areas and
diverse viewpoints. Preference is given to candidates who are citizens
of the United States. Aspects that are considered at the time of
candidate screening and review for inclusion in nomination packages
forwarded to the Secretary, DHHS, include:
<bullet> Geographical balance. Efforts are made to ensure that
voting members come from states representing a diversity of geographic
locations within the U.S.
<bullet> Balance of specialty areas (e.g., biostatistics,
toxicology, immunology, epidemiology, pediatrics, internal medicine,
family medicine, nursing, consumer issues, state and local health
department perspective, academic perspective, public health
perspective, etc.).
The ACIP Secretariat, including the DFO, solicits candidate names
through the following channels:
<bullet> Procedures for application for ACIP membership are
detailed on the ACIP website at <a href="https://www.cdc.gov/acip/membership/index.html">https://www.cdc.gov/acip/membership/index.html</a>. The ACIP Secretariat accepts applications as part of a
continuous process throughout the year.
<bullet> Solicitation of potential candidates is posted annually in
the Federal Register.
<bullet> Applications are solicited at ACIP meetings. A web link
URL is provided on a meeting slide, and procedures for application are
announced at the opening of meetings, which are broadcast via the
internet (``webcast'') to an audience that can exceed 10,000 viewers.
Members, including the Chair and Vice Chair, shall be selected and
appointed by the HHS Secretary and shall be invited to serve for
overlapping terms of up to four years, except that any member appointed
to fill a vacancy for an unexpired term shall be appointed for the
remainder of that term. A member may serve 180 days after the
expiration of that member's term if a successor has not taken office.
4. List of all other Federal advisory committees of the agency:
<bullet> Advisory Board on Radiation and Worker Health
<bullet> Advisory Committee for the Elimination of Tuberculosis
<bullet> Advisory Committee on Breast Cancer in Young Women
<bullet> Advisory Committee to the Director, CDC
<bullet> Board of Scientific Counselors, National Center for Injury
Prevention and Control
<bullet> Lead Exposure and Prevention Advisory Committee
<bullet> Mine Safety and Health Research Advisory Committee
<bullet> National Committee on Vital and Health Statistics
<bullet> World Trade Center Health Program Scientific/Technical
Advisory Committee
5. Justification that the information or advice provided by the
Federal advisory committee or subcommittee is not available from
another Federal advisory committee, another Federal Government source,
or any other more cost-effective and less burdensome source: The ACIP
has been given statutory roles under subsections 1928(c)(2)(B)(i) and
1928(e) of the Social Security Act (42 U.S.C. 1396s(c)(2)(B)(i) and
1396s(e)) and subsection 2713(a)(2) of the Public Health Service Act
(42 U.S.C. 300gg-13(a)(2)). In accordance with Section
[[Page 17280]]
1928 of the Social Security Act, the ACIP shall establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to children and adolescents eligible to receive
vaccines through the Vaccines for Children Program, along with
schedules regarding the appropriate dose and dosing interval, and
contraindications to administration of the pediatric vaccines. The
Secretary, and as delegated the CDC Director, shall use the list
established by the ACIP for the purpose of the purchase, delivery, and
administration of pediatric vaccines in the Vaccines for Children
Program. Further, under provisions of the Affordable Care Act (Section
2713 of the Public Health Service Act, as amended), immunization
recommendations of the Committee that have been adopted by the Director
of the Centers for Disease Control and Prevention must be covered by
applicable health plans. Therefore, the advice provided by the ACIP is
not available from another Federal advisory committee or Federal
Government source, or any other more cost-effective and less burdensome
source.
6. If the consultation is a committee renewal, a summary of the
previous accomplishments of the committee and the reasons it needs to
continue:
Summary of the previous accomplishments: Over the past two years,
the Committee met over six times during calendar years 2024 and 2025.
The Committee deliberated, offered recommendations, and/or revised over
15 recommendations during January 1, 2024, through December 31, 2025.
The Committee also recommended updated child/adolescent and adult
immunization schedules which CDC adopted and published in 2024 and
2025. Current information about ACIP activities can be found at:
<a href="https://www.cdc.gov/acip/index.html">https://www.cdc.gov/acip/index.html</a>.
Reasons for the continuation: During the next two years, the ACIP
is anticipated to work on and/or advise on the following initiatives:
<bullet> convene new work groups as needed in response to new
vaccine development, emerging evidence, and/or the review of existing
vaccine-related data);
<bullet> ensure publication of the child/adolescent and adult
immunization schedules in professional society journals/websites, in
addition to MMWR publication and posting on the CDC website;
<bullet> continue to implement consistent procedures across the
ACIP work groups;
<bullet> continue to refine the evidence-based process for
development of ACIP vaccine recommendations;
<bullet> continue to improve processes to ensure transparency and
opportunity for public comment during deliberations; and
<bullet> conduct continuing education activities for ACIP members
to enhance their understanding of the role of health economic
evaluations, and the evidence-based recommendations process, in
development of vaccine recommendations.
7. Explanation of why the committee/subcommittee is essential to
the conduct of agency business: The Secretary, Department of Health and
Human Services (HHS), and by delegation the Director, Centers for
Disease Control and Prevention (CDC), are authorized under Section 311
and Section 317 of the Public Health Service Act, [42 U.S.C. 243 and 42
U.S.C. 247b], as amended, to assist states and their political
subdivisions in the prevention and control of communicable diseases; to
advise the states on matters relating to the preservation and
improvement of the public's health; and to make grants to states and,
in consultation with the state health authorities, to agencies and
political subdivisions of states to assist in meeting the costs of
communicable disease control programs. Vaccines have played an
important role in public health around the globe. The Advisory
Committee on Immunization Practices (ACIP) provides recommendations to
the Director of the Centers for Disease Control and Prevention (CDC) on
the use of vaccines and immunization program strategies to inform
individuals, clinicians, and broader public health efforts. This
committee convenes scientific and medical experts to provide
recommendations based on the best available evidence of vaccine risks
and benefits, and efficacy. The ACIP shall provide advice and guidance
to the CDC Director regarding use of vaccines and related agents for
effective control of vaccine-preventable diseases and/or decrease
symptomatology in the civilian population of the United States
including identifying areas where additional data or evaluation would
be useful to inform future recommendations. Recommendations made by the
ACIP are initially reviewed by the CDC Director, and if adopted, become
official CDC/HHS recommendations, and may be published in the Morbidity
and Mortality Weekly Report (MMWR). The CDC Director informs the HHS
Secretary, and Assistant Secretary for Health, of immunization
recommendations provided by ACIP. Upon the licensure or authorization
of any vaccine or any new indication for a vaccine, the Committee
shall, as appropriate, consider the use of the vaccine at its next
regularly scheduled meeting. If the Committee does not make a
recommendation at the Committee's first regularly scheduled meeting,
the Committee shall provide an update on the status of such for the
Committee's review.
In conclusion, this public interest determination documents that
renewing the committee is in the public interest, essential to the
conduct of agency business, and that the information to be obtained is
not already available through another advisory committee or source
within the Federal Government.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2026-06577 Filed 4-3-26; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 6, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.